Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 2, 2008, Pages

  Zhang, Zhi Hua ^a   Yu, Yang ^a   Kang, Yu Ming ^a   Wei, Shun Guang ^a   Felder, Robert B ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin II type 1 receptor; Angiotensin converting enzyme; Central nervous system; Mineralocorticoid receptor; Sympathetic nerve activity

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II [1 SARCOSINE 8 THREONINE]; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN; MESSENGER RNA; NORADRENALIN; OXPRENOATE POTASSIUM; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART RATE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NONHUMAN; NORADRENALIN BLOOD LEVEL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC NERVE; SYMPATHETIC TONE; THALAMUS MIDLINE NUCLEUS; UPREGULATION;

ALDOSTERONE; ANIMALS; BLOOD PRESSURE; BRAIN CHEMISTRY; ELECTROPHYSIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; HEART RATE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MALE; OXIDATIVE STRESS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, MINERALOCORTICOID; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDES;

EID: 39149132486     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01131.2007     Document Type: Article

References (61)

1. American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 283: R281-R283, 2002.
2. Birmingham MK, Sar M, Stumpf WE. Localization of aldosterone and corticosterone in the central nervous system, assessed by quantitative autoradiography. Neurochem Res 9: 333-350, 1984.
3. Callera GE, Montezano AC, Yogi A, Tostes RC, He Y, Schiffrin EL, Touyz RM. c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats. Hypertension 46: 1032-1038, 2005.
4. Callera GE, Touyz RM, Tostes RC, Yogi A, He Y, Malkinson S, Schiffrin EL. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension 45: 773-779, 2005.
5. Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 46: 533-539, 2005.
6. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol 287: H695-H703, 2004.
7. Dai X, Cao X, Kreulen DL. Superoxide anion is elevated in sympathetic neurons in DOCA-salt hypertension via activation of NADPH oxidase. Am J Physiol Heart Circ Physiol 290: H1019-H1026, 2006.
8. Davisson RL. Physiological genomic analysis of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 285: R498-R511, 2003.
9. 3H]aldosterone by the anterior pituitary and brain regions in adrenalectomized rats. Horm Metab Res 13: 103-106, 1981.
10. Felder RB, Francis J, Zhang ZH, Wei SG, Weiss RM, Johnson AK. Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol 284: R259-R276, 2003.
11. Fiebeler A, Nussberger J, Shagdarsuren E, Rong S, Hilfenhaus G, Al-Saadi N, Dechend R, Wellner M, Meiners S, Maser-Gluth C, Jeng AY, Webb RL, Luft FC, Muller DN. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation 111: 3087-3094, 2005.
12. Francis J, Chu Y, Johnson AK, Weiss RM, Felder RB. Acute myocardial infarction induces hypothalamic cytokine synthesis. Am J Physiol Heart Circ Physiol 286: H2264-H2271, 2004.
13. Funder J, Myles K. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. Endocrinology 137: 5264-5268, 1996.
14. Gao L, Schultz HD, Patel KP, Zucker IH, Wang W. Augmented input from cardiac sympathetic afferents inhibits baroreflex in rats with heart failure. Hypertension 45: 1173-1181, 2005.
15. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 95: 937-944, 2004.
16. Gomez-Sanchez EP. Central hypertensive effects of aldosterone. Front Neuroendocrinol 18: 440-462, 1997.
17. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE. Is aldosterone synthesized within the rat brain? Am J Physiol Endocrinol Metab 288: E342-E346, 2005.
18. Gomez-Sanchez EP, Fort CM, Gomez-Sanchez CE. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol Endocrinol Metab 258: E482-E484, 1990.
19. Gomez-Sanchez EP, Venkataraman MT, Thwaites D, Fort C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol Endocrinol Metab 258: E649-E653, 1990.
20. Gomez-Sanchez EP, Zhou M, Gomez-Sanchez CE. Mineralocorticoids, salt and high blood pressure. Steroids 61: 184-188, 1996.
21. Gomez-Sanchez EP. Dose-response studies of intracerebroventricular infusion of aldosterone in sensitized and non-sensitized rats. J Hypertens 6: 437-442, 1988.
22. Harada E, Yoshimura M, Yasue H, Nakagawa O, Nakagawa M, Harada M, Mizuno Y, Nakayama M, Shimasaki Y, Ito T, Nakamura S, Kuwahara K, Saito Y, Nakao K, Ogawa H. Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation 104: 137-139, 2001.
23. Hendler NH, Livingston A. The localization over time of exogenous aldosterone and angiotensin II in various organs. Pavlov J Biol Sci 13: 187-193, 1978.
24. Hirono Y, Yoshimoto T, Suzuki N, Sugiyama T, Sakurada M, Takai S, Kobayashi N, Shichiri M, Hirata Y. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system. Endocrinology 148: 1688-1696, 2007.
25. Huang BS, Cheung WJ, Wang H, Tan J, White RA, Leenen FH. Activation of the brain renin-angiotensin-aldosterone system by central sodium in Wistar rats. Am J Physiol Heart Circ Physiol 291: H1109-H1117, 2006.
26. Huang BS, Wang H, Leenen FH. Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats. Am J Physiol Heart Circ Physiol 288: H517-H524, 2005.
27. Infanger DW, Sharma RV, Davisson RL. NADPH oxidases of the brain: distribution, regulation, and function. Antioxid Redox Signal 8: 1583-1596, 2006.
28. Kang YM, Zhang ZH, Johnson RF, Yu Y, Beltz T, Johnson AK, Weiss RM, Felder RB. Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure. Circ Res 99: 758-766, 2006.
29. Klar J, Vitzthum H, Kurtz A. Aldosterone enhances renin gene expression in juxtaglomerular cells. Am J Physiol Renal Physiol 286: F349-F355, 2004.
30. Lindley TE, Doobay MF, Sharma RV, Davisson RL. Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res 94: 402-409, 2004.
31. Marney AM, Brown NJ. Aldosterone and end-organ damage. Clin Sci (Lond) 113: 267-278, 2007.
32. Matsukawa K, Ninomiya I. Anesthetic effects on tonic and reflex renal sympathetic nerve activity in awake cats. Am J Physiol Regul Integr Comp Physiol 256: R371-R378, 1989.
33. Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension 47: 656-664, 2006.
34. Pan YX, Gao L, Wang WZ, Zheng H, Liu D, Patel KP, Zucker IH, Wang W. Exercise training prevents arterial baroreflex dysfunction in rats treated with central angiotensin II. Hypertension 49: 519-527, 2007.
35. Paxinos G, Watson C. The Rat Brain Is Stereotaxic Coordinates. Sydney, Australia: Academic, 1986.
36. Peterson JR, Sharma RV, Davisson RL. Reactive oxygen species in the neuropathogenesis of hypertension. Curr Hypertens Rep 8: 232-241, 2006.
37. Peysner K, Henry CA, Malvin RL. Central infusion of aldosterone increases blood pressure by mechanisms independent of Na retention. Clin Exp Hypertens A 12: 399-414, 1990.
38. 1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. Hypertension 33: 981-986, 1999.
39. Roizen MF, Moss J, Henry DP, Weise V, Kopin IJ. Effect of general anesthetics on handling- and decapitation-induced increases in sympathoadrenal discharge. J Pharmacol Exp Ther 204: 11-18, 1978.
40. Sakai K, Agassandian K, Morimoto S, Sinnayah P, Cassell MD, Davisson RL, Sigmund CD. Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest 117: 1088-1095, 2007.
41. Sakai K, Sigmund CD. Molecular evidence of tissue renin-angiotensin systems: a focus on the brain. Curr Hypertens Rep 7: 135-140, 2005.
42. Schiffrin EL, Franks DJ, Gutkowska J. Effect of aldosterone on vascular angiotensin II receptors in the rat. Can J Physiol Pharmacol 63: 1522-1527, 1985.
43. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, Abe Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41: 266-273, 2003.
44. Stocker SD, Cunningham JT, Toney GM. Water deprivation increases Fos immunoreactivity in PVN autonomic neurons with projections to the spinal cord and rostral ventrolateral medulla. Am J Physiol Regul Integr Comp Physiol 287: R1172-R1183, 2004.
45. Sugiyama T, Yoshimoto T, Tsuchiya K, Gochou N, Hirono Y, Tateno T, Fukai N, Shichiri M, Hirata Y. Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells. Endocrinology 146: 3900-3906, 2005.
46. Sun Y, Weber KT. Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration. J Lab Clin Med 122: 404-411, 1993.
47. Touyz RM. Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. Braz J Med Biol Res 37: 1263-1273, 2004.
48. Uhr M, Holsboer F, Muller MB. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol 14: 753-759, 2002.
49. Wang H, Huang BS, Leenen FH. Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension. Am J Physiol Heart Circ Physiol 285: H2516-H2523, 2003.
50. Wang J, Yu L, Solenberg PJ, Gelbert L, Geringer CD, Steinberg MI. Aldosterone stimulates angiotensin-converting enzyme expression and activity in rat neonatal cardiac myocytes. J Card Fail 8: 167-174, 2002.
51. Yu Y, Kang YM, Zhang ZH, Wei SG, Chu Y, Weiss RM, Felder RB. Increased cyclooxygenase-2 expression in hypothalamic paraventricular nucleus in rats with heart failure: role of nuclear factor kappaB. Hypertension 49: 511-518, 2007.
52. Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez EP, Weiss RM, Felder RB. Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure. Hypertension. In press.
53. Yu Y, Zhang ZH, Wei SG, Chu Y, Heistad DD, Weiss RM, Felder RB. Central gene transfer of interleukin-10 reduces hypothalamic inflammation and evidence of heart failure in rats after myocardial infarction. Circ Res 101: 304-312, 2007.
54. Zhang ZH, Felder RB. Melanocortin receptors mediate the excitatory effects of blood-borne murine leptin on hypothalamic paraventricular neurons in rat. Am J Physiol Regul Integr Comp Physiol 286: R303-R310, 2004.
55. Zhang ZH, Kang YM, Yu Y, Wei SG, Schmidt TJ, Johnson AK, Felder RB. 11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Hypertension 48: 127-133, 2006.
56. Zhang ZH, Wei SG, Francis J, Felder RB. Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins. Am J Physiol Regul Integr Comp Physiol 284: R916-R927, 2003.
57. Zhao X, White R, Huang BS, Van Huysse J, Leenen FH. High salt intake and the brain renin-angiotensin system in Dahl salt-sensitive rats. J Hypertens 19: 89-98, 2001.
58. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91: 1038-1045, 2002.
59. Zucker IH. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48: 1005-1011, 2006.
60. Zucker IH, Pliquett RU. Novel mechanisms of sympatho-excitation in chronic heart failure. Heart Fail Monit 3: 2-7, 2002.
61. Zucker IH, Wang W, Pliquett RU, Liu JL, Patel KP. The regulation of sympathetic outflow in heart failure. The roles of angiotensin II, nitric oxide, and exercise training. Ann NY Acad Sci 940: 431-443, 2001.